ANTI-VEGF ANTIKÖRPER

European patent · EP2220114 · In force

Register entry

Publication number
EP2220114
Application number
EP08857287
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 1, 2008
Published
Aug 25, 2010
Granted
Jan 14, 2015
Protection ends at the latest
Nov 30, 2028
Next annual fee due
Dec 31, 2026
IPC classes
C07K 16/00 (2006.01)
C07K 16/22 (2006.01)
C07K 16/32 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
C12N 15/13 (2006.01)
Priority
US 991302 P 30.11.2007
PCT application
PCT/US2008/013248 01.12.2008
PCT publication
WO2009/073160 11.06.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Apr 10, 2015

    Agent entered

    Representative
    F. HOFFMANN-LA ROCHE AG, Grenzacherstrasse 124, 4070 Basel

    Published in Swissreg on 10.04.2015

  6. Jan 14, 2015

    Granted

    Published in Swissreg on 14.01.2015

Parties

Holder

GENENTECH, INC.

Genentech, Inc.

1 DNA Way, South San Francisco, CA 94080-4990, US

Agent

F. Hoffmann-La Roche AG

F. HOFFMANN-LA ROCHE AG

Grenzacherstrasse 124, 4070 Basel

Inventor

FUH, Germaine

Pacifica, CA 94044, US

LEE, Chingwei, V.

Foster City, CA 94404, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.